ELEVATED SERUM LP(A) LEVELS IN THE EARLY AND ADVANCED STAGES OF BREAST-CANCER

被引：1
|
作者：
KOKOGLU, E
KARAARSLAN, I
KARAARSLAN, HM
BALOGLU, H
机构：
[1] SISLI ETFAL HOSP,DEPT INTERNAL MED 4,ISTANBUL,TURKEY
[2] GULHANE MIL MED ACAD,DEPT PATHOL,ISTANBUL,TURKEY
来源：
CANCER BIOCHEMISTRY BIOPHYSICS | 1994年 / 14卷 / 02期
关键词：
HUMAN BREAST CANCER; LIPOPROTEIN (A);
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Recently, lipoprotein (a) [Lp (a)] levels were found to be elevated in various types of cancer. This study was designed to evaluate the role of serum Lp (a) in early and advanced stages of breast cancer. Pasting venous blood samples were collected from 18 patients with Stage I, and 21 patients with Stage IV disease and were analysed for Lp (a). The results were compared with data from 22 healthy female controls. Patients with both Stage 1 and Stage IV disease had significantly higher (p < 0.001) Lp (a) concentrations than did healthy controls. Lp (a) was also found to be significantly elevated in Stage IV patients when compared with the Stage I group. Our data suggest that there is a highly significant association between Lp (a) and the presence and progression of breast cancer, and that serum Lp (a) determination may provide an aid in patients with breast cancer for both diagnostic purposes and the follow-up of the disease.
引用
收藏
页码：133 / 136
页数：4
相关论文
共 50 条
  • [31] ELEVATED CYCLIC-AMP LEVELS IN HUMAN BREAST-CANCER TISSUE
    MINTON, JP
    WISENBAUGH, T
    MATTHEWS, RH
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (01): : 283 - 284
  • [32] CORRELATION OF SERUM RETINOL LEVELS WITH RESPONSE TO CHEMOTHERAPY IN BREAST-CANCER
    BROWN, RR
    SOUKOP, M
    TORMEY, DC
    AREND, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 184 - 184
  • [33] SERUM PROLACTIN LEVELS IN WOMEN WITH BREAST-CANCER AND THEIR RELATIONSHIP TO SURVIVAL
    WANG, DY
    HAMPSON, S
    KWA, HG
    MOORE, JW
    BULBROOK, RD
    FENTIMAN, IS
    HAYWARD, JL
    KING, RJB
    MILLIS, RR
    RUBENS, RD
    ALLEN, DS
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (04): : 487 - 492
  • [34] SERUM OSTEOCALCIN LEVELS IN PATIENTS WITH PRIMARY AND METASTATIC BREAST-CANCER
    GOERNER, R
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 793 - 796
  • [35] RHYTHMIC FLUCTUATIONS OF CEA SERUM LEVELS IN BREAST-CANCER PATIENTS
    JAGER, W
    DIEDRICH, M
    SAUERBREI, W
    WILDT, L
    ANTICANCER RESEARCH, 1987, 7 (04) : 711 - 715
  • [36] THE PROGNOSTIC VALUE OF SERUM IGE LEVELS IN PRIMARY BREAST-CANCER
    OWNBY, D
    OWNBY, H
    ROI, L
    HOWARD, L
    BAKER, L
    HEPPNER, G
    BRENNAN, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 150 - 150
  • [37] PROGNOSTIC RELEVANCE OF SERUM HYALURONAN LEVELS IN PATIENTS WITH BREAST-CANCER
    PONTING, J
    HOWELL, A
    PYE, D
    KUMAR, S
    INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (06) : 873 - 876
  • [38] THE EFFECT OF TOREMIFENE THERAPY ON SERUM IMMUNOGLOBULIN LEVELS IN BREAST-CANCER
    PAAVONEN, T
    ARONEN, H
    PYRHONEN, S
    HAJBA, A
    ANDERSSON, LC
    APMIS, 1991, 99 (09) : 849 - 853
  • [39] Serum Copper Levels In Different Stages Of Breast Cancer.
    Shyamala, B.
    Taranikanti, Madhuri
    Archana, R.
    Balasankar, Ramavath
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (02): : 1190 - 1194
  • [40] ELEVATED SOLUBLE C-ERBB-2 ANTIGEN LEVELS IN THE SERUM AND EFFUSIONS OF A PROPORTION OF BREAST-CANCER PATIENTS
    LEITZEL, K
    TERAMOTO, Y
    SAMPSON, E
    MAUCERI, J
    LANGTON, BC
    DEMERS, L
    PODCZASKI, E
    HARVEY, H
    SHAMBAUGH, S
    VOLAS, G
    WEAVER, S
    LIPTON, A
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) : 1436 - 1443
12345